Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ)

被引：94
作者：
Ristow, Oliver [1 ,2 ]
Otto, Sven [3 ]
Troeltzsch, Matthias [3 ]
Hohlweg-Majert, Bettina [2 ,4 ]
Pautke, Christoph [2 ,3 ]
机构：
[1] Heidelberg Univ, Dept Oral & Maxillofacial Surg, D-69120 Heidelberg, Germany
[2] Clin Oral & Maxillofacial & Plast Surg, D-80333 Munich, Germany
[3] Univ Munich, Dept Oral & Maxillofacial Surg, D-80336 Munich, Germany
[4] Tech Univ Munich, Dept Oral & Maxillofacial Surg, D-81675 Munich, Germany
来源：
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY | 2015年 / 43卷 / 02期
关键词：
Bisphosphonate; Denosumab; Osteonecrosis of the jaw; BRONJ; Surgical treatment; Fluorescence-guided bone resection; BISPHOSPHONATE-RELATED OSTEONECROSIS; GUIDED BONE RESECTION; RISK-FACTORS; FOLLOW-UP; SURGICAL RESECTION; MULTIPLE-MYELOMA; CANCER-PATIENTS; CASE SERIES; FLUORESCENCE; MANAGEMENT;
D O I：
10.1016/j.jcms.2014.11.014
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
The medication-related osteonecrosis of the jaw (MRONJ) is believed to be a therapy-resistant entity. Although the application of the recommended conservative and surgical treatment regimens have returned variable success rates, the increased awareness and experience with MRONJ suggests that surgical therapy can halt the progression of the disease, thereby allowing a histology-based diagnosis of the osteonecrosis. Surgical treatment protocols can achieve success rates of over 90% and novel techniques such as the visualization of bone fluorescence can assist in the intra-operative delineation of the osteonecrosis and standardize the procedure. (C) 2014 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：290 / 293
页数：4
相关论文
共 57 条
  • [51] Osteopathology associated with bone resorption inhibitors - which role does Actinomyces play? A presentation of 51 cases with systematic review of the literature[J]. Schipmann, S.;Metzler, P.;Roessle, M.;Zemann, W.;von Jackowski, J.;Obwegeser, J. A.;Graetz, K. W.;Jacobsen, C. JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2013(08)
  • [52] Identification of microbial biofilms in osteonecrosis of the jaws secondary to bisphosphonate therapy[J]. Sedghizadeh, Parish P.;Kumar, Satish K. S.;Gorur, Amita;Schaudinn, Christoph;Shuler, Charles F.;Costerton, J. William. JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2008(04)
  • [53] Osteotomy and primary wound closure in bisphosphonate-associated osteonecrosis of the jaw: a prospective clinical study with 12 months follow-up[J]. Stockmann, Philipp;Vairaktaris, Eleftherios;Wehrhan, Falk;Seiss, Martin;Schwarz, Stephan;Spriewald, Bernd;Neukam, Friedrich-Wilhelm;Nkenke, Emeka. SUPPORTIVE CARE IN CANCER, 2010(04)
  • [54] Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome[J]. Van den Wyngaert, T.;Claeys, T.;Huizing, M. T.;Vermorken, J. B.;Fossion, E. ANNALS OF ONCOLOGY, 2009(02)
  • [55] Early Surgical Laser-Assisted Management of Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ): A Retrospective Analysis of 101 Treated Sites with Long-Term Follow-Up[J]. Vescovi, Paolo;Manfredi, Maddalena;Merigo, Elisabetta;Guidotti, Rebecca;Meleti, Marco;Pedrazzi, Giuseppe;Fornaini, Carlo;Bonanini, Mauro;Ferri, Teore;Nammour, Samir. PHOTOMEDICINE AND LASER SURGERY, 2012(01)
  • [56] Surgical treatment of bisphosphonate-associated osteonecrosis of the jaw: Technical report and follow up of 21 patients[J]. Voss, Pit Jacob;Oshero, Joel Joshi;Kovalova-Mueller, Alice;Merino, Egle Alina Veigel;Sauerbier, Sebastian;Al-Jamali, Jamil;Lemound, Juliana;Metzger, Marc Christian;Schmelzeisen, Rainer. JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY, 2012(08)
  • [57] Intravenous bisphosphonate-related osteonecrosis of the jaw: Long-term follow-up of 109 patients[J]. Watters, Amber L.;Hansen, Heidi J.;Williams, Tijaana;Chou, Joanne F.;Riedel, Elyn;Halpern, Jerry;Tunick, Steven;Bohle, George;Huryn, Joseph M.;Estilo, Cherry L. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 2013(02)
123456